文献速递神经MR

ASL皮质高流量征联合MRS胱硫醚预测IDH突变胶质瘤1p/19q状态

The diagnostic value of cortical high-flow sign combined with cystathionine on 1H-MRS for prediction of 1p/19q-codeletion status in IDH-mutant adult-type diffuse glioma.
PubMed 文献 · Neuroradiology · 2026-01-24

本研究在IDH突变成人型弥漫性胶质瘤中,比较ASL皮质高流量征与1H-MRS胱硫醚浓度对1p/19q共缺失状态的判别能力。两者联合的AUC达到0.875,优于单一参数。

要点

  • ASL见皮质高流量征提示IDH突变胶质瘤更可能为1p/19q共缺失型少突胶质细胞瘤
  • 1H-MRS测得胱硫醚浓度升高支持1p/19q共缺失,但需注意CRLB低于50%的质控标准
  • 皮质高流量征与胱硫醚联合使用可提高对1p/19q状态的术前预测效能

核心结论

  • ASL皮质高流量征联合1H-MRS胱硫醚水平可区分IDH突变伴1p/19q共缺失的少突胶质细胞瘤与IDH突变无1p/19q共缺失的星形细胞瘤,联合AUC为0.875

研究设计与样本

  • ASL采用伪连续式技术,标记后延迟为2000ms,通过标记像与对照像相减生成相对灌注图
  • 1H-MRS采用单体素PRESS序列,TR为2000ms、TE为97ms、激励次数为128、感兴趣容积为203mm³
  • 仅纳入2.7ppm处胱硫醚Cramér-Rao下界低于50%的病例作为质控标准

关键影像表现/征象

  • 皮质高流量征在少突胶质细胞瘤组出现比例为7/12(58.3%),在星形细胞瘤组为3/18(16.7%)

诊断标准与关键数值

  • 少突胶质细胞瘤组胱硫醚浓度为1.50±0.63mM,星形细胞瘤组为0.85±0.24mM(p=0.001)

临床应用与阅片要点

  • 术前ASL发现皮质高流量征时应将其纳入胶质瘤分子分型预测的影像依据
  • 1H-MRS报告中胱硫醚浓度升高可作为支持1p/19q共缺失的代谢信息
  • 联合皮质高流量征与胱硫醚浓度较单一参数更能辅助鉴别少突胶质细胞瘤与星形细胞瘤

局限性

  • 研究对象限定为IDH突变胶质瘤,未涉及IDH野生型肿瘤

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To leverage a combination of cortical high-flow sign on arterial spin labeling (ASL) and cystathionine measurement using 1H-MR spectroscopy (1H-MRS) to distinguish oligodendroglioma, IDH-mutant and 1p/19q-codeleted (O_IDHm-codel) from astrocytoma, IDH-mutant (A_IDHm-noncodel).

MATERIALS AND METHODS: We implemented pseudo-continuous ASL technique (post-labeling delay = 2000 ms) using a 3.0-T MRI scanner. Relative perfusion maps were generated by subtracting paired labeled images from control images. 1H-MRS data were acquired by using the single-voxel point-resolved spectroscopy sequence (PRESS) sequence (TR = 2000 ms, TE = 97 ms, NEX = 128, volume of interest = 203 mm3). Our study included cases with a Cramér-Rao Lower Bound of cystathionine levels at 2.7 ppm that were below 50%. The presence or absence of cortical high-flow sign and the estimated concentration of cystathionine were compared between A_IDHm-noncodel and O_IDHm-codel. The receiver operating characteristic curves were used to evaluate the diagnostic performance of each parameter, as well as the combination of both.

RESULTS: The cortical high-flow sign was identified more frequent in O_IDHm-codel (7/12, 58.3%) than in A_IDHm-noncodel (3/18, 16.7%; p = 0.018). The cystathionine levels in O_IDHm-codel (1.50 ± 0.63 mM) was significantly higher than in A_IDHm-noncodel (0.85 ± 0.24 mM; p = 0.001). The area under the curve for distinguishing O_IDHm-codel from A_IDHm-noncodel using the presence of cortical high-flow sign, cystathionine levels, and their combination was 0.708 (0.509-0.908), 0.750 (0.553-0.947), and 0.875 (0.737-1.000), respectively.

CONCLUSION: The presence of cortical high-flow sign on ASL, along with elevated cystathionine levels measured by 1H-MRS, could differentiate O_IDHm-codel from A_IDHm-noncodel.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Yamashita, Tomiyasu, Kikuchi, et al. The diagnostic value of cortical high-flow sign combined with cystathionine on 1H-MRS for prediction of 1p/19q-codeletion status in IDH-mutant adult-type diffuse glioma. Neuroradiology. 2026. PMID: 41579156. doi:10.1007/s00234-026-03909-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。